#fabry-disease

icon subthematics
Imaging of Arthritis and Metabolic Bone Disease E-Book
Category

Ebooks

Imaging of Arthritis and Metabolic Bone Disease E-Book

Barbara N. W. Weissman

Imaging of Arthritis and Metabolic Bone Disease E-Book Alternate Text
Category

Ebooks

Medecine

Imaging of Arthritis and Metabolic Bone Disease E-Book

Barbara N. W. Weissman

Book

1679 pages

Flag

English

icon play Lire
icon play Infos
Measuring patient experiences in Fabry disease: validation of the Fabry-specific Pediatric Health and Pain Questionnaire (FPHPQ)
Category

Documents

Measuring patient experiences in Fabry disease: validation of the Fabry-specific Pediatric Health and Pain Questionnaire (FPHPQ)

Ramaswami Uma, Stull, Parini Rossella, Pintos-Morell Guillem, Whybra Catharina, Kalkum Gisela, Rohrbach Marianne, Raluy-Callado Mireia, Beck Michael, Chen Wen-Hung, Wiklund Ingela, On

Measuring patient experiences in Fabry disease: validation of the Fabry-specific Pediatric Health and Pain Questionnaire (FPHPQ) Alternate Text
Category

Documents

Savoirs

Measuring patient experiences in Fabry disease: validation of the Fabry-specific Pediatric Health and Pain Questionnaire (FPHPQ)

Ramaswami Uma, Stull, Parini Rossella, Pintos-Morell Guillem, Whybra Catharina, Kalkum Gisela, Rohrbach Marianne, Raluy-Callado Mireia, Beck Michael, Chen Wen-Hung, Wiklund Ingela, On

Book

9 pages

Flag

English

icon play Lire
icon play Infos
Safety and pharmacodynamic effects of a pharmacological chaperone on α-galactosidase A activity and globotriaosylceramide clearance in Fabry disease: report from two phase 2 clinical studies
Category

Documents

Safety and pharmacodynamic effects of a pharmacological chaperone on α-galactosidase A activity and globotriaosylceramide clearance in Fabry disease: report from two phase 2 clinical studies

Giugliani Roberto, Mehta Atul, Nicholls Kathy, Barisoni Laura, Jennette, Bragat Alexander, Castelli Jeff, Sitaraman Sheela, Lockhart, Germain, Hughes, Boudes

Safety and pharmacodynamic effects of a pharmacological chaperone on α-galactosidase A activity and globotriaosylceramide clearance in Fabry disease: report from two phase 2 clinical studies Alternate Text
Category

Documents

Savoirs

Safety and pharmacodynamic effects of a pharmacological chaperone on α-galactosidase A activity and globotriaosylceramide clearance in Fabry disease: report from two phase 2 clinical studies

Giugliani Roberto, Mehta Atul, Nicholls Kathy, Barisoni Laura, Jennette, Bragat Alexander, Castelli Jeff, Sitaraman Sheela, Lockhart, Germain, Hughes, Boudes

Book

11 pages

Flag

English

icon play Lire
icon play Infos
Alternate Text